THE validation of Guyana by the World Health Organization (WHO) for eliminating mother-to-child transmission of HIV and syphilis as public-health problems is a landmark achievement that deserves recognition nationally.
Above all, it is a powerful testimony to what sustained investment, effective public-health policies and a dedicated health workforce can do to save the lives of mothers and children.
This recognition, confirmed in a letter dated November 16, 2026 from WHO Director General Dr Tedros Adhanom Ghebreyesus to Health Minister Dr Frank Anthony, places Guyana in a select group of countries in Latin America and the Caribbean to have achieved this significant public-health milestone.
The organisation validated Guyana’s achievement for the period 2022 to 2025 after an assessment by WHO’s Global Validation Advisory Committee on November 5.
This is an international award for the government and nothing else. This is a real step forward in the country’s ability to protect vulnerable people, prevent unnecessary infections and give children a healthier start in life.
Behind that validation are screened and treated mothers, protected-from-infection infants and health care professionals whose work has helped to deliver those results.
The significance of this achievement cannot be overstated. Mother-to-child transmission of HIV and syphilis can have devastating consequences such as lifelong infection, stillbirth and neonatal death.
But nearly all these outcomes can be avoided by timely treatment, early detection and regular antenatal care. Guyana’s success proves that the results can be up to the highest international standards when these essential services are available and well coordinated.
The achievement also underscores the critical importance of continuity in public-health investment. More than sporadic interventions are needed for screening of pregnant women, access to appropriate medication, improvement of laboratory services and maintenance of reliable disease surveillance.
They need regular funding, trained staff, functioning health facilities and an effective system that can reach women in all parts of the country.
Under the leadership of President, Dr Mohamed Irfaan Ali, healthcare modernisation has remained a key national priority, with investments focused on hospitals, primary health care facilities, diagnostic services, medical equipment and the development of the healthcare workforce.
The investments are part of a broader effort to upgrade the country’s healthcare delivery system and access to quality services.
But, the true measure of healthcare transformation should be in improved health outcomes and not just in the building of facilities or acquisition of equipment. Guyana’s WHO validation is important because it brings international recognition for tangible progress in preventing disease and saving lives.
The difficult process to get this recognition just stresses how important it is. The assessment, coordinated by the Pan American Health Organization (PAHO), involved a virtual review from June 1-5, 2026, and an in-country mission from June 7-13. The regional validation team reviewed national programmes, laboratory systems, epidemiological data, health-care delivery, community engagement, human rights and gender issues Additional scrutiny came from the WHO’s Global Validation Advisory Committee.
Dr Tedros, WHO Director-General, praised the government for its continued commitment to a robust programme safeguarding expectant mothers and their babies. This recognition is especially significant as it confirms that Guyana’s efforts have been measured against internationally accepted criteria and not just on national claims of progress.
The doctors, nurses, midwives, laboratory professionals, public-health officers and community health workers at the centre of this achievement also deserve credit.
Their work is often behind the scenes but is critical to the success of maternal and child healthcare programmes. We cannot forget the invaluable contributions of PAHO, WHO, development partners, civil society organisations and families.
However, national pride must be tempered with a good understanding that validation does not mean HIV and syphilis are history in Guyana, but it does confirm that mother-to-child transmission has been reduced to the internationally agreed levels required for elimination as a public-health problem.
This is important as the achievement can only be maintained with continued vigilance, screening, treatment and surveillance.
The next challenge, in fact, may be as big as the accomplishment: keeping the momentum going. WHO flags Guyana.








